IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,731,802 | – | 4,698 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 5,300,000 | $6,265,000 | 0.59% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,457,000 | $5,272,000 | 0.40% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,416,000 | $12,314,000 | 0.28% |
| AQR Arbitrage LLC | 7,700,000 | $9,119,000 | 0.26% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,227,000 | $25,018,000 | 0.22% |
| LINDEN ADVISORS LP | 26,849,000 | $31,752,000 | 0.19% |
| HBK INVESTMENTS L P | 10,000,000 | $11,822,000 | 0.05% |
| Calamos Advisors LLC | 7,500,000 | $8,910,000 | 0.04% |
| Jefferies Group LLC | 3,245,000 | $3,856,677 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,700,000 | $11,487,000 | 0.02% |